Immunological Profiles and prognostic outcomes in patients with alcoholic hepatitis
酒精性肝炎患者的免疫学特征和预后结果
基本信息
- 批准号:10190739
- 负责人:
- 金额:$ 21.15万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-09-22 至 2023-06-30
- 项目状态:已结题
- 来源:
- 关键词:AbstinenceAcuteAdaptive Immune SystemAffectAlcohol abuseAlcohol consumptionAlcoholic HepatitisAlcoholic Liver CirrhosisAlcoholic Liver DiseasesAlcoholic beverage heavy drinkerAlcoholsAntibody AffinityAntibody ResponseApplications GrantsAreaB-LymphocytesBacterial InfectionsBacterial TranslocationBindingBlood CirculationCD4 Positive T LymphocytesCell Differentiation processCell LineageCellsClinicalComplexComplicationDNADataDefectDiseaseDisease OutcomeEndotoxinsEthanolFibrosisFunding OpportunitiesGoalsHealthHeavy DrinkingHelper-Inducer T-LymphocyteHepaticHepatitis B VaccinationHepatocyteHumanIL8 geneImmuneImmunologic MemoryImmunologicsImpairmentInflammationInflammatoryInflammatory ResponseInjuryInnate Immune ResponseIntestinal permeabilityLeadLightLinkLipopolysaccharidesLiver diseasesMalignant NeoplasmsMorbidity - disease rateNatural ImmunityNeutrophiliaOutcomePathogenesisPathway interactionsPatient-Focused OutcomesPatientsPeripheral Blood Mononuclear CellPlasmaPneumoniaProcessReactionResearchRisk FactorsRodent ModelRoleSecondary toSeriesSeverity of illnessStructure of germinal center of lymph nodeT-LymphocyteTestingTimeToll-like receptorsTranslational ResearchVaccinesViolenceVirus Diseasesadaptive immune responseadaptive immunitycell typechemokinechronic alcohol ingestionclinically significantcytokineeffective therapyfollow-upimmune activationinfection riskliver injurylongitudinal analysismacrophagemicrobialmonocytemortalityneutrophilnew therapeutic targetnovelproblem drinkerprognosticprognostic significanceresponsesecondary lymphoid organsurvival outcome
项目摘要
Project Summary
Alcoholic hepatitis is a leading cause of morbidity and mortality in the US. Despites its complicated
pathogenesis, one of the key drivers in the disease process is the alterations in the innate and adaptive immune
responses secondary to excessive alcohol use. This application is in response to the funding opportunity
“Alcoholic hepatitis clinical and translational network – translational research (RFA-AA-18-003)”. The goal
of our application is to better understand the role and mechanism of innate and adaptive immunity in the
pathogenesis of alcoholic hepatitis, as this may help us identify novel therapeutic targets to treat this severe
form of ALD. Two specific aims are proposed: Aim# 1: Determine the impact and prognostic significance of
microbial translocation, immune dysregulation on the disease severity and outcomes in patients with AH. In
this aim, we hypothesized that (i) the state of immune dysregulation has the impact on baseline disease
severity and long term outcome of patients with AH and (ii) persistent immune activation during the follow
up despite abstinence is adversely affected outcomes of patients with AH. We found that ethanol primes
peripheral blood mononuclear cells for LPS-induced inflammatory responses. In sub-aim#1.1, we will perform
a detail cross sectional/longitudinal analysis on baseline gut permeability, microbial translocation, immune cell
activation/inflammation in healthy controls, ED without liver diseases, and those with AH. We also found that
plasma IL-8, a potent chemokine for neutrophils, were markedly elevated in patients with AH. The induction
of neutrophils leads to hepatic inflammation/injury with the release of mitochrondrial-DNA containing
microparticles (MPs) from the hepatocytes; perpetuating neutrophilia and liver injury. In sub-aim#1.2, we will
determine the role and clinical significance of IL-8 and mitochrondrial-DNA (mt-DNA) in patients with AH.
Aim#2: Determine the mechanism and significance of alteration in follicular helper T cells in patients with
AH. Little is known about how alcohol affects the adaptive immune system, despite the increase risk of
infections among those with excessive alcohol use. Follicular T helper (TFH) cells are a CD4 T cell lineage
uniquely found in the germinal center reaction of secondary lymphoid organs. The specific function of TFH
cells is to select B cells in the germinal center that produce high-affinity Abs. Our novel preliminary data
showed, for the first time, on the effect of excessive drinking and ALD on circulating TFH (cTFH) cells. In this
aim, we hypothesized that excessive alcohol consumption leads to altered cTFH cell differentiation, and that
these effects on cTFH cells are augmented and impacted survival outcomes in patients with AH. We will test
that (i) AH patients have dysregulation of cTFH cells, (ii) AH patients have T cell-intrinsic or T cell-extrinsic
defects that alter cTFH cell differentiation, and, and (iii) AH patients have abnormal B cell responses secondary
to dysregulation in cTFH cells. Our results may shed light on the treatment of AH by targeting specific
immunological pathways linking to the pathogenesis of AH.
项目摘要
酒精性肝炎是美国发病率和死亡率的主要原因。尽管它的复杂
在发病机制中,疾病过程中的关键驱动因素之一是先天性和适应性免疫系统的改变,
继发于过量饮酒的反应。这份申请是为了响应
酒精性肝炎临床和转化网络-转化研究(RFA-AA-18-003)。目标
我们的应用是为了更好地了解先天性和适应性免疫在免疫系统中的作用和机制。
酒精性肝炎的发病机制,因为这可能有助于我们确定新的治疗靶点,以治疗这种严重的
ALD的形式。提出了两个具体目标:目标1:确定以下因素的影响和预后意义:
微生物易位、免疫失调对AH患者疾病严重程度和预后的影响。在
为此,我们假设(i)免疫失调状态对基线疾病有影响,
AH患者的严重程度和长期结局,以及(ii)随访期间持续的免疫激活
尽管禁欲,但对AH患者的结局有不利影响。我们发现乙醇引发
外周血单核细胞用于LPS诱导的炎症反应。在子目标#1.1中,我们将执行
对基线肠道通透性、微生物易位、免疫细胞、
在健康对照、无肝病的艾德和具有AH的那些中的活化/炎症。我们还发现
AH患者的血浆IL-8(一种有效的中性粒细胞趋化因子)显着升高。感应
中性粒细胞的释放导致肝脏炎症/损伤,
从肝细胞的微粒(MP);永久嗜中性粒细胞和肝损伤。在分目标1.2中,我们将
目的探讨IL-8和线粒体DNA(mitochondrial-DNA,mt-DNA)在AH中的作用及临床意义。
目的#2:确定滤泡辅助性T细胞改变的机制和意义,
啊关于酒精如何影响适应性免疫系统,人们知之甚少,尽管酒精会增加免疫系统的风险。
过度饮酒者的感染。滤泡性T辅助细胞(TFH)是一种CD 4 T细胞谱系
仅见于次级淋巴器官的生发中心反应。TFH的特殊功能
细胞是选择生发中心产生高亲和力抗体的B细胞。我们新的初步数据
首次显示了过量饮酒和ALD对循环TFH(cTFH)细胞的影响。在这
目的,我们假设过量饮酒导致cTFH细胞分化改变,
这些对cTFH细胞的作用增强并影响AH患者的存活结果。我们将测试
(i)AH患者具有cTFH细胞的失调,(ii)AH患者具有T细胞内源性或T细胞外源性
改变cTFH细胞分化的缺陷,和(iii)AH患者具有异常的B细胞应答继发性
cTFH细胞中的失调。我们的研究结果可能为AH的治疗提供线索,
与AH发病机制相关的免疫途径。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Suthat Liangpunsakul其他文献
Suthat Liangpunsakul的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Suthat Liangpunsakul', 18)}}的其他基金
FKBP5 in the pathogenesis of alcohol-associated liver disease
FKBP5 在酒精相关性肝病发病机制中的作用
- 批准号:
10501012 - 财政年份:2022
- 资助金额:
$ 21.15万 - 项目类别:
FKBP5 in the pathogenesis of alcohol-associated liver disease
FKBP5 在酒精相关性肝病发病机制中的作用
- 批准号:
10704686 - 财政年份:2022
- 资助金额:
$ 21.15万 - 项目类别:
S-adenosylmethionine treatment in alcoholic cirrhosis
S-腺苷甲硫氨酸治疗酒精性肝硬化
- 批准号:
10022083 - 财政年份:2019
- 资助金额:
$ 21.15万 - 项目类别:
S-adenosylmethionine treatment in alcoholic cirrhosis
S-腺苷甲硫氨酸治疗酒精性肝硬化
- 批准号:
10247836 - 财政年份:2019
- 资助金额:
$ 21.15万 - 项目类别:
S-adenosylmethionine treatment in alcoholic cirrhosis
S-腺苷甲硫氨酸治疗酒精性肝硬化
- 批准号:
10491274 - 财政年份:2019
- 资助金额:
$ 21.15万 - 项目类别:
Novel animal models to study miRNA-mediated alcoholic liver disease
研究 miRNA 介导的酒精性肝病的新型动物模型
- 批准号:
9794130 - 财政年份:2018
- 资助金额:
$ 21.15万 - 项目类别:
Novel animal models to study miRNA-mediated alcoholic liver disease
研究 miRNA 介导的酒精性肝病的新型动物模型
- 批准号:
10205559 - 财政年份:2018
- 资助金额:
$ 21.15万 - 项目类别:
Novel animal models to study miRNA-mediated alcoholic liver disease
研究 miRNA 介导的酒精性肝病的新型动物模型
- 批准号:
10228102 - 财政年份:2018
- 资助金额:
$ 21.15万 - 项目类别:
Immunological Profiles and prognostic outcomes in patients with alcoholic hepatitis
酒精性肝炎患者的免疫学特征和预后结果
- 批准号:
10440367 - 财政年份:2018
- 资助金额:
$ 21.15万 - 项目类别:
Novel animal models to study miRNA-mediated alcoholic liver disease
研究 miRNA 介导的酒精性肝病的新型动物模型
- 批准号:
10430148 - 财政年份:2018
- 资助金额:
$ 21.15万 - 项目类别:
相似海外基金
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 21.15万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 21.15万 - 项目类别:
Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 21.15万 - 项目类别:
Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 21.15万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 21.15万 - 项目类别:
Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 21.15万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 21.15万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 21.15万 - 项目类别:
Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 21.15万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
- 批准号:
484000 - 财政年份:2023
- 资助金额:
$ 21.15万 - 项目类别:
Operating Grants














{{item.name}}会员




